Skip to content

Public FDA record

Z-2077-2025: ColoSense Test Kit, Part No. 80-001, component of ColoSense test

Recall record Z-2077-2025 for Geneoscopy, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2077-2025
Company in FDA record
Geneoscopy, Inc.
FDA classification date
Jul 3, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Multiple plate failures documented as a result of the Low Positive Template Control being too high and out of range using the affected lot of ColoSense Test Kit.

Source facts

Action
On May 20, 2025, the firm initiated a voluntary removal of the affected test kit lot. An internal recall notification was sent to the affected CLIA Laboratory Director. All remaining test kits were removed from the CLIA laboratory. The firm's investigation of the root cause for this issue is ongoing.
Initiated
2025-05-20
Root cause
Unknown/Undetermined by firm
Distribution
US Nationwide distribution in the state of Missouri.
Recall number
Z-2077-2025
Recall status
Open, Classified
CDRH record ID
214221
FDA classified
2025-07-03
Recall event number
97017

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗